Navigation Links
Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Award
Date:12/5/2018

Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award.

Jean Bennett, M.D., Ph.D., and Katherine A. High, M.D., whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on Dec. 4 at Sanford Health, headquartered in Sioux Falls, South Dakota.

“I want to thank the Sanford Health system for rewarding innovation,” said High. “There were many days we were discouraged, so it’s so wonderful for an award to be given for people who made it across the finish line.”

Bennett expressed her gratitude and said that the patients are the real pioneers.

Four finalists competed for the prize, intended to reward contributions to medicine, science and innovation. The women were chosen in an 8-1 vote of the Sanford International Board.

“No matter who we picked, it was going to be a great winner. They are all winners. But even more, we are all winners,” said Andy North, president of the Sanford International Board. The board heard from the candidates in a private presentation on Tuesday morning, with the winner announced at a ceremony that evening.

Gene therapy quickly stood out as the field of candidates was narrowed, said David Pearce, Ph.D., president of research at Sanford Health, who noted that these four finalists helped lay the groundwork for much of the innovative work that is being explored now.

“We want to make a difference. It’s a culture that delivers on the idea that if you make a promise here, that’s a promise kept,” said Kelby Krabbenhoft, president and CEO of Sanford Health, during the award ceremony. “Let’s start curing things. Let’s make a difference. The world will be better because of you.”

Bennett and High pioneered the gene therapy for the RPE65 mutation, took it to clinical trials and then received the first FDA approval of a gene therapy for a genetic disease. High also co-founded Spark Therapeutics, a fully integrated, commercial gene therapy company working to accelerate the timeline for bringing new gene therapies to market. Bennett is a professor of ophthalmology at the University of Pennsylvania and a scientific co-founder of Spark Therapeutics, and High is president and head of research and development at Spark Therapeutics.

The other finalists were:

  • Brian Kaspar, Ph.D., whose lab discovered a gene replacement therapy approach that seeks to change the course of spinal muscular atrophy (SMA) by addressing its genetic cause. SMA is a devastating disease that robs babies of basic muscle functions, like breathing and swallowing, and in its most severe form (Type 1), usually leads to death by age 2. An initial clinical trial using the AAV9 vector to treat SMA Type 1 demonstrated a dramatic survival benefit and rapid improvement in motor milestones. Kaspar is the scientific founder and chief scientific officer of AveXis, a gene therapy company that was acquired by Novartis in 2018.
  • James M. Wilson, M.D., Ph.D., whose work paved the way for many groups to safely move promising gene therapies for inherited and acquired diseases through the translational pipeline internationally. He is the director of the Gene Therapy Program, the Rose H. Weiss Professor and Director of the Orphan Disease Center, and a professor of Medicine and Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. In 2008, Wilson and the University of Pennsylvania cofounded REGENXBIO, Inc., a clinical-stage biotech company designing gene therapy products.

Candidates for the award were filtered through nominations from the public and a computer algorithm that sifted through medical publications in search of great discoveries. An interdisciplinary scientific advisory board identified top areas of innovation and the candidates were narrowed down to the top four.

The award is named after the Lorraine Cross, a symbol recognized around the world synonymous for those who take action for their passions. In recent history, Sanford Health has used it to symbolize innovation in health care.

About Sanford Health
Sanford Health is one of the largest health care systems in the nation with 44 hospitals and nearly 1,400 physicians in nine states and nine countries. Headquartered in Sioux Falls, South Dakota, and serving the Upper Midwest, Sanford Health is dedicated to several initiatives, including global clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health has nearly 30,000 employees, making it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford over the past decade have transformed how Sanford Health can improve the human condition. For information, visit http://www.sanfordhealth.org.

Read the full story at https://www.prweb.com/releases/gene_therapy_pioneers_win_1_million_sanford_lorraine_cross_award/prweb15954732.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
2. Puerto Ricos Caribbean Imaging and Radiation Therapy Center Orders Elektas New Versa HD System for Treatment of Cancer Patients
3. New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System
4. The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
5. BioElectronics and Pulsed Shortwave Therapy Make Progress
6. Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions
7. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
8. Leeds St Jamess Institute of Oncology Acquires Two Elekta Versa HD Radiotherapy Systems
9. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
10. Charlotte Based Compression And Vacuum Therapy Technology Helps Train Cyclist In Race Across America
11. Positive Generex Data Underscores Cancer Immunotherapy Forecast Issued by Citi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... BOSTON (PRWEB) , ... December 05, 2018 , ... WHO: ... care worldwide , WHAT: Livestreaming of four keynote addresses and five spotlight ... Health Care (see below for session descriptions and speakers) , WHEN: Beginning Tuesday, December ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Cyber Regulatory Waters , **An FDAnews Webinar**, Tuesday, Dec. 18, 2018, 1:30 ... get, the more vulnerable they become. , Cybersecurity is becoming an everyday risk. ...
(Date:12/5/2018)... ... December 05, 2018 , ... Smart pill ... achieve better health outcomes, today announced the launch of its new user-oriented nutritional ... Pillsy and will leverage its pioneering technology to enhance users’ control of, and ...
Breaking Medicine Technology:
(Date:12/6/2018)... WORCESTER, Mass. (PRWEB) , ... December 06, 2018 ... ... wormwood plant cured the tropical disease schistosomiasis significantly faster than the drug most ... trial conducted in the Democratic Republic of Congo. The study’s authors, including a ...
(Date:12/5/2018)... CITY, Tenn. and DALLAS, Texas (PRWEB) , ... ... ... aesthetics team, again proved its leading SkinPen Precision device is setting a new ... of its record-setting Aesthetics Everything win. , Each year this award is presented ...
(Date:12/5/2018)... ... 05, 2018 , ... Northeast Delta Human Services Authority will ... Monroe Baptist Church, 210 Finks Hideaway Rd, Monroe, LA 71203. , The training ... educate and equip faith leaders to address substance abuse prevention, support and recovery ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Jessica Allen of Northern Colorado Periodontics is ... ailing dental implants in the Fort Collins area. Dr. Allen joins an elite class ... bone and tissues lost to gum disease. , "Gum disease is a problem that ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... the healthcare provider market, announced today that it was ranked #184 on Deloitte’s ... companies with the highest growth in the fields of technology, media, telecommunications, life ...
Breaking Medicine News(10 mins):